- 21297 Foothill Blvd. Ste 203 Hayward, CA 94541-1554
- (408) 290-9440
- (415) 636-9700
- hello@exxceedwellness.com
In 2019, a multicenter, randomized, double-blind clinical trial published in The American Journal of Psychiatry reported something significant: targeted transcranial magnetic stimulation produced statistically meaningful reductions in OCD symptoms compared to sham treatment.
Participants in the active treatment group showed greater decreases on the Yale-Brown Obsessive Compulsive Scale (Y-BOCS), the gold standard measurement tool for OCD severity. This was not anecdotal improvement. It was measured, replicated, and strong enough to support FDA clearance of a TMS protocol for OCD.
That study marked a turning point. OCD was no longer treated only with medication and behavioral therapy. It could now be addressed at the level of neural circuitry.
OCD is increasingly understood as a disorder of a specific brain network called the cortico-striato-thalamo-cortical (CSTC) loop.
This circuit connects:
In OCD, this loop becomes overactive. The brain’s internal “error detection” system does not quiet down. Even when no danger is present, the alarm keeps firing.
That persistent signal is what makes intrusive thoughts feel urgent and compulsions feel necessary.
TMS works by delivering focused magnetic pulses to specific cortical regions involved in this overactive loop. Over repeated sessions, stimulation can alter neural excitability and influence downstream network activity.
In the Carmi et al. 2019 trial, stimulation of prefrontal targets led to meaningful reductions in symptom severity compared to sham treatment. The implication is direct: by modulating cortical control regions, TMS can reduce hyperactivity in the broader OCD circuit.
It does not eliminate intrusive thoughts entirely. What it may do is lower the intensity of the signal driving them, making compulsions easier to resist and behavioral therapy more effective.
Exposure and Response Prevention (ERP) remains the gold standard for OCD. Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed.
But for patients who complete ERP and trial medications without sufficient relief, the question becomes whether the circuit itself needs targeted modulation.
TMS offers a noninvasive method of influencing that circuit directly.
For patients with co-occurring depression — common in moderate to severe OCD — TMS may also impact overlapping mood-regulation networks.
TMS for OCD is delivered in an outpatient setting, typically five days per week for several weeks. Patients remain awake and resume normal activity afterward.
Side effects are generally mild and may include temporary scalp discomfort or headache. Serious adverse events are rare when appropriate screening protocols are followed.
Because not every TMS clinic offers OCD-specific protocols, confirming the type of stimulation used is important.
FDA-cleared TMS for OCD is available in California, including the Bay Area.
If you live in Castro Valley, Hayward, San Leandro, Fremont, or surrounding East Bay communities and continue to struggle with OCD despite therapy or medication, a psychiatric consultation can determine whether TMS targeting OCD-related circuits is appropriate.
We provide structured evaluation, insurance verification, and treatment planning before beginning care.
Contact our office to schedule a consultation.
This article is for educational purposes only and does not constitute medical advice. A specific TMS protocol has received FDA clearance for the treatment of Obsessive-Compulsive Disorder in adults. Individual responses vary. TMS does not replace evidence-based psychotherapy such as Exposure and Response Prevention (ERP). Treatment decisions should be made in consultation with qualified healthcare professionals following comprehensive evaluation.
